The Metformin Active Surveillance Trial (MAST) Study

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This study aims to see if metformin can delay the time to progression in men with low risk prostate cancer when compared to a placebo.
Epistemonikos ID: 4675c20719e8bd7afe6f9760ac00b426669b794b
First added on: May 11, 2024